Skip to main content
Industry News
Lonza gains Swiss nod to start producing Moderna vaccine

The Lonza Group has gained the approval of Swiss drug regulator Swissmedic to begin manufacturing Moderna Therapeutics' COVID-19 vaccine at a facility in Switzerland, according to the newspaper SonntagsZeitung. Swissmedic is expected to approve Moderna's COVID-19 vaccine soon following its approval of Pfizer and partner BioNTech's vaccine.

Full Story: